Testicular seminoma (pure) stage II

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
3 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Platinum compound 2 substances
Topoisomerase II inhibitor 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Swiss Group for Clinical Cancer Research Academic
    CARBOPLATIN; CISPLATIN; ETOPOSIDE
    2023-509663-24-00 1 country 2020 n=95
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Swiss Group for Clinical Cancer Research Academic 1 Phase II 0
New trials by year
2020
1
← All indication landscapes